Skip to main navigation

ABOUT US
Company Profile Executive Management Board of Directors Clinical Advisory Board
OUR PIPELINE
OUR SCIENCE
FOR PATIENTS
INVESTORS & MEDIA
Overview News & Press Releases Presentations Events SEC Filings Stock Quote & Chart Senior Management Board of Directors Board Committees Corporate Governance Clinical Advisory Board Analyst Coverage RSS Feeds Contact Us
CONTACT US

Presentations

Breadcrumb

Home
Investors
Presentations

SAB Corporate Presentation

May 13, 2026

ISPAD 2025 Conference Presentation - Blood Preservation Methods

November 7, 2025

ISPAD 2025 Conference Presentation - Mechanism of Action of hATG

November 7, 2025

ISPAD 2025 Conference - ePOSTER Safety Profile of SAB-142 A Fully Human Anti-Thymocyte Globulin

November 7, 2025

ISPAD 2025 Conference Presentation - Immunomodulation Without Depletion

November 7, 2025

ISPAD 2025 Conference - ePOSTER Novel PK Assay

November 7, 2025

ISPAD 2025 Conference Presentation - CD Marker Characterization

November 7, 2025

INNODIA at EASD 2025 - Working to Change the Lives of People Impacted by T1D

September 19, 2025

EASD 2025 Conference Presentation - Mechanism of Action of hATG

September 19, 2025

EASD 2025 Conference Presentation - Novel PK Assay

September 19, 2025

EASD 2025 Conference Presentation - Blood Preservation Methods

September 19, 2025

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Shareholder Tools

Print Page
Email Alerts
RSS
Investor FAQs

Social Media Menu

©2026 SAb Biotherapeutics, Inc.
All Rights Reserved
Terms & Conditions
Privacy Policy
Conflict of Interest Policy
Contact Us